U.S. CDC, India Explore AI Tools to Detect Drug Resistance in Hours, Not Days
Updated
Updated · The Indian EYE · Jun 8
U.S. CDC, India Explore AI Tools to Detect Drug Resistance in Hours, Not Days
2 articles · Updated · The Indian EYE · Jun 8
Summary
CDC medical officer Ashley Styczynski is in India under the Embassy Science Fellows Program to map how U.S. support can speed antimicrobial-resistance detection and response with AI.
Days-long lab testing is a central bottleneck: machine-learning tools could predict whether bacteria resist antibiotics in minutes or hours, helping doctors choose treatment sooner or avoid unnecessary antibiotic use.
More than 1 million deaths a year are now linked to antimicrobial resistance, which also threatens routine surgeries, chemotherapy and HIV care by weakening the antibiotics modern medicine depends on.
More than 80 sources in India and Nepal are feeding the fellowship review, with India seen as a key partner because of its pathogen data, surveillance systems and capacity to adapt AI models to local microbial patterns.
The effort fits a broader U.S.-India health-security push in which AI is also being tested for genome analysis, infection monitoring and screening millions of compounds for new antibiotics.